Page 361 - Clinical Small Animal Internal Medicine
P. 361

33  Surgical Approaches to Thoracic Disease  329

               therapy for protein replacement in critically ill patients is   sodium ion concentration within the airways, increasing
  VetBooks.ir  to provide enteral nutrition in order for the patient to   pulmonary stretch receptor activity.
               synthesize albumin.


               Oxygen Therapy                                     Hypothermia
                                                                  Hypothermia is an inevitable occurrence during and
               Oxygen therapy may be provided intermittently via face-  immediately following thoracic surgery. Warming IV
               mask or continuously by nasopharyngeal insufflation,   fluids prior to administration can help diminish
               nasal prongs, oxygen cage, or intubation and mechanical   large  reductions in intraoperative body temperature.
               ventilation. Provision of intermittent supplemental oxy-  Postoperative temperature monitoring, either intermit-
               gen at an FiO 2  of 50–60% can be achieved via facemask   tent or continuous, is recommended to ensure euther-
               with oxygen flow rates of 8.0–12.0 L/min. Nasopharyngeal   mia and active warming using warming blankets or
               insufflation or nasal prongs may be utilized with oxygen   heat lamps should be performed until the patient’s tem-
               flow rates of 50–150 mL/kg/min to achieve an FiO 2  of   perature has reached 99.5 °F.
               30–70%. More commonly, postoperative thoracotomy
               patients are maintained in an oxygen cage with flow rates   Arrhythmias
               of 0.5–1.0 L/min to maintain a FiO 2  of 40–60%. Patients
               requiring an FiO 2  above 60% to maintain normoxemia   For hemodynamically significant, multifocal, sus-
               will likely require intubation and mechanical ventilation.   tained, or R‐on‐T phenomena ventricular arrhythmias,
               Caution must be exercised to avoid oxygen toxicity when   lidocaine remains the mainstay therapy. Lidocaine may
               supplemental oxygen levels are maintained above 60%   also be useful to slow the heart rate, allowing differen-
               for more than 24 hours.                            tiation of ventricular tachycardia from sinus tachycar-
                 When mechanical ventilation is utilized, PEEP ven-  dia with bundle branch block. The waveform of the
               tilation can be beneficial to prevent atelectasis and   latter often will not change following lidocaine bolus
               augment work of breathing. In contrast to the sponta-  (2.0 mg/kg IV), but P‐waves may be appreciable once
               neously breathing patient, permissive hypercapnia is   the heart rate has decelerated. For lidocaine‐respon-
               tolerated in mechanically ventilated postthoracotomy   sive arrhythmias, a constant rate infusion of 60–80 μg/
               patients. Arterial PCO 2  may rise to 50 mmHg before   kg/min may be implemented postoperatively. A beta‐
               intervention is necessary, as long as normoxemia is   blocker may also be  considered for patients that do not
               maintained. Proper humidification is an important   have known underlying cardiac disease with compro-
               component of oxygen therapy for preservation of    mised contractility. Anecdotally, sotalol 2.0 mg/kg PO
               proper mucociliary function and clearance of respira-  BID has favorable postoperative antiarrhythmic
               tory secretions.                                     properties for patients with supraventricular and ven-
                                                                  tricular tachyarrhythmias.
               Dyspnea
                                                                  Nursing Care
               Dyspnea is the perceived feeling of breathlessness. The
               pathophysiology of dyspnea is multifactorial and is   Nursing care is a critical yet often underemphasized
               described elsewhere. Multiple therapeutic targets have   aspect of postthoracotomy care. Patients undergoing
               been investigated to decrease the perception of dyspnea   median sternotomy often prefer lateral recumbency in
               in human patients. In human studies, nebulized or aero-  the immediate postoperative period due to incisional
               solized furosemide has been found to prevent bronchoc-  pain. Turning or rotating the patient every 4–6 hours
               onstriction  and inhibit  the cough  reflex  in addition  to   prevents atelectasis and V–Q mismatching secondary to
               reducing pulmonary vascular hydrostatic pressure and   gravitational forces in lateral recumbency. Turning the
               edema when absorbed systemically. Furosemide has   patient also promotes patient comfort and hygiene.
               been  shown  experimentally  and  clinically  in  people  to   Optimal analgesia aids in patient well‐being and may
               reduce bronchial slow‐acting receptors (SARs), thereby   promote tolerance of sternal recumbency and therefore
               reducing the sensation of dyspnea. Furosemide exerts a   improved oxygenation and ventilation.
               diuretic effect when administered by the enteral or par-
               enteral route via inhibition of the Na:K:2Cl co‐trans-  Complications
               porter within the thick ascending loop of Henle. A
               similar mechanism is  postulated for the antidyspneic   Complications  post  thoracotomy  may  include  edema
               effect of nebulized furosemide causing a local increase in   formation, hypoproteinemia, continual pleural effusion,
   356   357   358   359   360   361   362   363   364   365   366